Masitinib
| CAS No. | 790299-79-5 |
|---|---|
| MDL No. | MFCD09954132 |
| MF | C28H30N6OS |
| MW | 498.60 |
| InChI Key | WJEOLQLKVOPQFV-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Masitinib is a benzamide formed by the condensation of the carboxy group of 4-[(4-methylpiperazin-1-yl)methyl]benzoic acid with the primary amino group of 4-methyl-N(3)-[4-(pyridin-3-yl)-1,3-thiazol-2-yl]benzene-1,3-diamine. It is a highly selective oral tyrosine kinase inhibitor with roles as a tyrosine kinase inhibitor, antineoplastic agent, and antirheumatic drug. It belongs to the classes of N-alkylpiperazines, 1,3-thiazoles, pyridines, and benzamides.
| CAS No. | 790299-79-5 |
|---|---|
| Product Name | Masitinib |
Biological Targets
FGFR3·PDGFRB·PDGFRA·KIT
Associated Conditions
pancreatic carcinoma·metastatic melanoma·Alzheimer disease·asthma·neoplasm·
* The information provided here is compiled from public sources and is for reference only.
